Literature DB >> 23180879

Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.

Mandy Wan1, Colette Smith, Vanita Shah, Ambrose Gullet, David Wells, Lesley Rees, Rukshana Shroff.   

Abstract

BACKGROUND: Fibroblast growth factor 23 (FGF23), a bone-derived phosphaturic hormone, is elevated in chronic kidney disease (CKD). There are scarce data on the levels of its essential co-receptor klotho, and longitudinal changes in FGF23 levels are also unknown.
METHODS: We examined FGF23 and soluble klotho (s-klotho) levels over 1 year in 154 children with CKD Stages 1-5 (CKD1-5), were on dialysis or who have received a transplantation.
RESULTS: In children with CKD1-5 and who were receiving dialysis, FGF23 correlated inversely with the estimated glomerular filtration rate (eGFR) (P < 0.001), whereas a decrease in s-klotho was observed with a lower eGFR (P = 0.01). There was no correlation between FGF23 and serum phosphate (P) or parathyroid hormone (PTH) in our cohort wherein 89 and 66%, respectively, had normal levels. FGF23 increased by 6-fold over a 12-month period in children with eGFR of 15-29 mL/min/1.73 m(2), with an overall 5% annual increase in the CKD1-5 and dialysis cohort. High FGF23 levels were seen with high calcium (Ca) levels (P < 0.001). FGF23 levels were high when 25-hydroxyvitamin D [25(OH)D] and 1,25-dihydroxyvitamin D [1,25(OH)(2)D] were deficient (P = 0.05 and P < 0.001, respectively). s-klotho levels correlated positively with 25(OH)D (P < 0.001) and negatively with PTH (P = 0.04) and age (P = 0.03). Multivariate regression analysis demonstrated a strong relationship between FGF23 and eGFR, whereas the association between s-klotho and eGFR as observed in univariate analysis was lost following the adjustment of confounders. In transplanted patients, FGF23 correlated with eGFR (P = 0.02) and 25(OH)D (P = 0.05).
CONCLUSIONS: This study shows increasing FGF23 and reduced s-klotho levels with progressive renal failure even in a population of children with well-controlled P levels. Novel associations between FGF23 and serum Ca as well as 25(OH)D warrant further investigation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23180879     DOI: 10.1093/ndt/gfs411

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  39 in total

1.  FGF23 protein expression in coronary arteries is associated with impaired kidney function.

Authors:  Natalie A van Venrooij; Renata C Pereira; Yin Tintut; Michael C Fishbein; Navdeep Tumber; Linda L Demer; Isidro B Salusky; Katherine Wesseling-Perry
Journal:  Nephrol Dial Transplant       Date:  2014-01-23       Impact factor: 5.992

2.  Renal Production, Uptake, and Handling of Circulating αKlotho.

Authors:  Ming Chang Hu; Mingjun Shi; Jianning Zhang; Tayo Addo; Han Ju Cho; Sarah L Barker; Priya Ravikumar; Nancy Gillings; Ao Bian; Sachdev S Sidhu; Makoto Kuro-o; Orson W Moe
Journal:  J Am Soc Nephrol       Date:  2015-05-14       Impact factor: 10.121

3.  Klotho Deficiency and the Cardiomyopathy of Advanced CKD.

Authors:  Jürgen Floege; Danilo Fliser
Journal:  J Am Soc Nephrol       Date:  2014-10-17       Impact factor: 10.121

4.  Relationship of FGF23 to indexed left ventricular mass in children with non-dialysis stages of chronic kidney disease.

Authors:  Manish D Sinha; Charles Turner; Caroline J Booth; Simon Waller; Pernille Rasmussen; David J A Goldsmith; John M Simpson
Journal:  Pediatr Nephrol       Date:  2015-05-15       Impact factor: 3.714

5.  The anti-aging factor α-klotho during human pregnancy and its expression in pregnancies complicated by small-for-gestational-age neonates and/or preeclampsia.

Authors:  Jezid Miranda; Roberto Romero; Steven J Korzeniewski; Alyse G Schwartz; Piya Chaemsaithong; Tamara Stampalija; Lami Yeo; Zhong Dong; Sonia S Hassan; George P Chrousos; Philip Gold; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2013-08-19

Review 6.  Coronary artery calcification and cardiovascular disease in children with chronic kidney disease.

Authors:  Sara Paoli; Mark M Mitsnefes
Journal:  Curr Opin Pediatr       Date:  2014-04       Impact factor: 2.856

Review 7.  αKlotho and vascular calcification: an evolving paradigm.

Authors:  Ming Chang Hu; Makoto Kuro-o; Orson W Moe
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-07       Impact factor: 2.894

Review 8.  The Kidney-Vascular-Bone Axis in the Chronic Kidney Disease-Mineral Bone Disorder.

Authors:  Michael E Seifert; Keith A Hruska
Journal:  Transplantation       Date:  2016-03       Impact factor: 4.939

Review 9.  Fibroblast growth factor 23 and acute kidney injury.

Authors:  Javier A Neyra; Orson W Moe; Ming Chang Hu
Journal:  Pediatr Nephrol       Date:  2014-12-06       Impact factor: 3.714

Review 10.  αKlotho and Chronic Kidney Disease.

Authors:  J A Neyra; M C Hu
Journal:  Vitam Horm       Date:  2016-03-24       Impact factor: 3.421

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.